182 related articles for article (PubMed ID: 28397431)
1. The effects and safety of intravitreal triamcinolone injections in the treatment of diabetic macular edema.
Zając-Pytrus HM; Kaczmarek R; Strońska-Lipowicz D; Pomorska M; Misiuk-Hojło M
Adv Clin Exp Med; 2017; 26(1):45-49. PubMed ID: 28397431
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C
J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review.
Yilmaz T; Weaver CD; Gallagher MJ; Cordero-Coma M; Cervantes-Castaneda RA; Klisovic D; Lavaque AJ; Larson RJ
Ophthalmology; 2009 May; 116(5):902-11; quiz 912-3. PubMed ID: 19410949
[TBL] [Abstract][Full Text] [Related]
6. Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema.
Lee HY; Lee SY; Park JS
Korean J Ophthalmol; 2009 Sep; 23(3):153-8. PubMed ID: 19794940
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema.
Forte R; Cennamo GL; Finelli M; Farese E; D'Amico G; Nicoletti G; de Crecchio G; Cennamo G
Eye (Lond); 2010 Aug; 24(8):1325-30. PubMed ID: 20300127
[TBL] [Abstract][Full Text] [Related]
8. ISIS-DME: a prospective, randomized, dose-escalation intravitreal steroid injection study for refractory diabetic macular edema.
Kim JE; Pollack JS; Miller DG; Mittra RA; Spaide RF;
Retina; 2008 May; 28(5):735-40. PubMed ID: 18463518
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of postvitrectomy intravitreal triamcinolone therapy for diabetic macular edema.
Costa JF; Sousa K; Marques JP; Marques M; Cachulo ML; Silva R; Gomes N; Figueira J
Eur J Ophthalmol; 2016 Aug; 26(5):485-90. PubMed ID: 26951531
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of diabetic macular edema with intravitreal triamcinolone acetonide injection: functional and anatomical outcomes].
Selim Kocabora M; Kucuksahin H; Gulkilik G; Taskapili M; Yilmazli C; Engin G
J Fr Ophtalmol; 2007 Jan; 30(1):32-8. PubMed ID: 17287669
[TBL] [Abstract][Full Text] [Related]
11. Deferred intravitreal triamcinolone in diabetic eyes after phacoemulsification.
Campos A; Beselga D; Mendes S; Campos J; Neves A; Sousa P
J Ocul Pharmacol Ther; 2014 Nov; 30(9):717-28. PubMed ID: 25111757
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the short-term effects of intravitreal triamcinolone acetonide and bevacizumab injection for diabetic macular edema.
Song JH; Lee JJ; Lee SJ
Korean J Ophthalmol; 2011 Jun; 25(3):156-60. PubMed ID: 21655039
[TBL] [Abstract][Full Text] [Related]
13. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema--a comparative pilot study.
Norlaili M; Bakiah S; Zunaina E
BMC Ophthalmol; 2011 Nov; 11():36. PubMed ID: 22111945
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal steroids for macular edema in diabetes.
Grover D; Li TJ; Chong CC
Cochrane Database Syst Rev; 2008 Jan; (1):CD005656. PubMed ID: 18254088
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intravitreal triamcinolone acetonide versus intravitreal bevacizumab as the primary treatment of clinically significant macular edema.
Liu Q; Hu Y; Yu H; Yuan L; Hu J; Atik A; Guan M; Li D; Li X; Tang S
Retina; 2015 Feb; 35(2):272-9. PubMed ID: 25105313
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Efficacy of Sub-Tenon versus Intravitreal Triamcinolone Acetonide Injection during Cataract Surgery for Diabetic Macular Edema.
Tatsumi T; Oshitari T; Ando T; Takatsuna Y; Arai M; Baba T; Sato E; Yamamoto S
Ophthalmologica; 2019; 241(1):17-23. PubMed ID: 30041252
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone for diabetic macular edema: comparison of 1, 2, and 4 mg.
Hauser D; Bukelman A; Pokroy R; Katz H; Len A; Thein R; Parness-Yossifon R; Pollack A
Retina; 2008 Jun; 28(6):825-30. PubMed ID: 18536598
[TBL] [Abstract][Full Text] [Related]
19. Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema.
Gillies MC; Simpson JM; Gaston C; Hunt G; Ali H; Zhu M; Sutter F
Ophthalmology; 2009 Nov; 116(11):2182-7. PubMed ID: 19796823
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomised trial of different doses of intravitreal triamcinolone for diabetic macular oedema.
Lam DS; Chan CK; Mohamed S; Lai TY; Li KK; Li PS; Tsang CW; Chan WM; Shanmugam MP
Br J Ophthalmol; 2007 Feb; 91(2):199-203. PubMed ID: 16973659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
